Why is Torrent Pharma falling/rising?

As of 08-Jul, Torrent Pharmaceuticals Ltd. is experiencing a decline in its stock price, currently at 3,318.00, reflecting a decrease of 22.0 points or 0.66%. The stock has been under pressure, having fallen for the last two consecutive days, resulting in a total return of -1.48% during this period. Despite outperforming its sector by 0.27% today, the stock's delivery volume has significantly decreased by 78.59% compared to its 5-day average, indicating a drop in investor participation. Over the past week, the stock has declined by 2.79%, although it has shown a positive return of 5.29% over the last month and 15.21% over the past year, outperforming the BSE500 in each of the last three annual periods. The company maintains a strong financial position with high management efficiency, a low debt-to-EBITDA ratio, and consistent positive results over the last seven quarters, which supports its long-term viability.
In the broader market context, the Sensex has shown a slight increase of 0.02% over the past week, contrasting with Torrent's decline. While the stock has outperformed the benchmark over longer periods, its recent short-term performance has lagged behind, contributing to the current downward trend. The overall market sentiment appears to be more favorable than that of Torrent Pharmaceuticals in the short term, as evidenced by the benchmark's positive movement despite the stock's recent struggles.